For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty

2nd April 2025 Uncategorised 0

To innovators in the cell and gene therapy field, Peter Marks’ exit from the FDA means losing a seasoned regulator and key ally.

More: For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
Source: fierce